Company intelligence / Profile preview

Seerave Ventures

Unclear (likely US/Switzerland/UK, as parent is international)

Ownership: Private
Development stage: Other

Overview

Seerave Ventures is the venture investment arm of the Seerave Foundation, focused on supporting early-stage companies developing innovative microbiome-based health solutions. Its main objective is to accelerate the integration of microbiome science into clinical care, especially to mitigate the impact of microbiome modifiers like antibiotics on cancer immunotherapy outcomes. Seerave Ventures provides equity investments and strategic support to a select number of mission-aligned companies, but does not develop or operate its own clinical programs.

Therapeutic areas: OncologyGastroenterology
Modalities: Synthetic probioticEngineered probioticMedical foodMicrobiome analytics platform
Industry: Investors

Partnerships

Florey BiosciencesBiomeSenseHarvard Wyss Institute

Beyond the preview

Go deeper on Seerave Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seerave Ventures.

Explore the full profile